1. First-in-human dose-escalation study of VCN-01, a selective oncolytic adenovirus with hyaluronidase activity in patients with advanced or metastatic cancer. (December 2016) Authors: Hidalgo, M.; Gil, M.; Garcia-Carbonero, R.; Alvarez, R.; Laquente, B.; Moreno, R.; De Martino, A.; Alemany, R.; Capella, G.; Blasi, E.; Viaplana, I.; Cascallo, M.; Salazar, R. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S99 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Human Menstrual Blood-Derived Mesenchymal Stem Cells as Potential Cell Carriers for Oncolytic Adenovirus. (11th July 2017) Authors: Moreno, R.; Rojas, L. A.; Villellas, Felip Vilardell; Soriano, Vanessa Cervera; García-Castro, J.; Fajardo, C. A.; Alemany, R. Other Names: Colvin Gerald A. Academic Editor. Journal: Stem cells international Issue: Volume 2017(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗